CSF2 and neoplasm: In this strategy, immune checkpoint blockage by 9-ING-41 acts synergistically with the HY-oAd induced immunostimulatory transgenes IL-12 and GM-CSF, along with transgene relaxin-mediated ECM remodeling, to produce a robust anti-tumor response.